Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID‐19

BACKGROUND & AIMS: Little is known about cholestasis, including its most severe variant secondary sclerosing cholangitis (SSC), in critically ill patients with coronavirus disease 19 (COVID‐19). In this study, we analysed the occurrence of cholestatic liver injury and SSC, including clinical, se...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Liver Int
Prif Awduron: Bütikofer, Simon, Lenggenhager, Daniela, Wendel Garcia, Pedro D., Maggio, Ewerton M., Haberecker, Martina, Reiner, Cäcilia S., Brüllmann, Gregor, Buehler, Philipp K., Gubler, Christoph, Müllhaupt, Beat, Jüngst, Christoph, Morell, Bernhard
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2021
Pynciau:
Gut‐liver Axis, Immunology, Immune Mediated and Cholestatic Diseases
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8242687/
https://ncbi.nlm.nih.gov/pubmed/34018314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.14971
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg